Amendment to Schedule 13D Filing for Core Scientific, Inc.

This filing is an amendment to a Schedule 13D for Core Scientific, Inc., primarily detailing changes in beneficial ownership by Two Seas Capital LP and its related entities. As of March 4, 2026, Two Seas Capital LP, along with Two Seas Capital GP LLC and Sina Toussi, collectively hold approximately 5.9% of the company's common stock, amounting to 18,716,679 shares. This holding includes shares and exercisable options and warrants. The amendment details transactions conducted between February 19, 2026, and March 4, 2026, involving the purchase and sale of common stock and options/warrants across various funds and accounts managed by Two Seas Capital. The total value of securities held by these entities is substantial, with the aggregate purchase price for shares held by the Strategic Fund, Global Fund, and Accounts detailed in the filing. The reporting persons have delegated sole voting and investment power to TSC, with Sina Toussi exercising control as Chief Investment Officer.